Пред во NOVARTIS PHARMA SERVICES AG в РУ

Novartis Pharma Services AG in the Republic of Uzbekistan is the local representative office of Novartis, a global healthcare company headquartered in Switzerland. Novartis is a leading pharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative medicines and healthcare products worldwide. The Uzbekistan office primarily manages the company's commercial operations, including marketing, sales, regulatory affairs, and distribution of Novartis pharmaceutical products within the country. It serves as the local point of contact and support for healthcare professionals, patients, and governmental bodies, ensuring access to Novartis's treatments and adherence to local regulations.

This entity, Пред во NOVARTIS PHARMA SERVICES AG в РУ, is a representative office. It is not a factory that manufactures products. While it facilitates the sale and distribution of Novartis products in Uzbekistan, it is not an independent trading company. Instead, it acts as a local arm of the global pharmaceutical manufacturer, Novartis, supporting its business activities and market presence.

NOVARTIS PHARMA SERVICES AG in Uzbekistan (pred vo NOVARTIS PHARMA SERVICES AG v RU) makes available a broad portfolio of pharmaceutical products across various therapeutic areas, serving to distribute and market medicines developed and manufactured by Novartis globally. The representative office ensures the availability of these medicines to patients in Uzbekistan. The product portfolio generally includes treatments for cardiovascular, renal, and metabolic diseases such as Entresto for heart failure, Diovan and Exforge for hypertension, and Galvus for type 2 diabetes. In immunology, hepatology, and dermatology, a key product is Cosentyx, used for conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis. For neuroscience, Gilenya is available for the treatment of multiple sclerosis. The oncology portfolio includes products such as Kisqali for breast cancer, the combination of Tafinlar and Mekinist for melanoma and lung cancer, and Jakavi for myelofibrosis and polycythemia vera. In ophthalmology, Lucentis is offered for certain eye conditions. For rare diseases and gene therapy, Zolgensma is a notable product for spinal muscular atrophy. Additionally, the company provides established medicines like Voltaren for pain and inflammation, along with other established brands and generic formulations across different therapeutic categories. This selection represents the types of products and therapeutic areas that Novartis typically provides through its operations globally, including in Uzbekistan, all subject to local regulatory approvals and market needs.